PRACTICAL AND CLINICAL INSIGHT INTO TODAY'S GENERAL DERMATOLOGY ISSUES

Basal Cell Carcinoma


Skin and Aging is the most comphrehensive resource on the web regarding the subject of Basal Cell Carcinoma and how it affects dermatology professionals.  Feel free to browse through our articles below.

Basal Cell Carcinoma of the Skin: Molecular Studies and Rational Drug Development
While genetically-induced skin cancers are rare, understanding their mechanism provides insights into the causes and treatment of all skin cancers.


What Kind of Ear Piercing Is This?
Diagnosis: Basal Cell Carcinoma Causing Ear Piercing Basal Cell Carcinoma (BCC) is the most common skin cancer diagnosed in the United States, comprising up to 75% of nonmelanoma skin cancers.1 It arises from the basal layer of the epidermis, and although it has low metastatic potential, it may result in local destruction of the skin and surrounding structures. J Am Acad Dermatol 1990; 23: 694 23. Stenquist B, Wennberg AM, Gisslen H, Larko O. Treatment of aggressive basal cell carcinoma with...


What Is This Slow-Growing Pigmented Lesion?
Diagnosis: Pigmented Basal Cell Carcinoma (PBCC)Basal cell carcinoma (BCC) is the most common of all malignant skin tumors, with approximately 1 million new cases occurring annually and an increasing incidence in the United States.1 Most BCCs arise in the sun-exposed areas of the head and neck, and are more common in males, elderly patients and individuals with fair skin. found that pigment “speckling” in discrete, solitary skin-colored tumors was consistent with a diagnosis of ...


Cutaneous Epithelial Malignancies
Research findings, clinical experience and applications with newer agents.


What Is This Small Growth?
Diagnosis: Fibroepithelioma of PinkusDespite the debate about its true nature, fibroepithelioma of Pinkus (FEP) is considered a rare variant of basal cell carcinoma (BCC) with an approximate frequency of 0.3% to 1.4%. ” Recently, authors have debated whether this lesion is benign or malignant.5,7 Bowen and Leboit5 conducted a study that concludes FEP is more similar to trichoblastoma, a benign neoplasm with primitive hair follicle differentiation,8 than to BCC, a malignant ...


Skin Cancer in African-Americans
Skin Cancer in African-Americans Insights Into Ethnic Skin and Hair: Skin Cancer in African-Americans - By Heather Woolery-Lloyd, M.D. S kin cancers are less frequently observed in African-American patients. Overall Distribution One study of 215 patients compared the distribution of all skin cancers in Caucasian and Hispanic patients to African-American patients. Although both African-American and Caucasian patients in the irradiated group were more likely to develop BCC, the greater ...


Part 2: CME #125: What Did We Learn in 2005?
Highlights of research, controversies and technological advances for this past year.


Skin Cancer Update
Highlights of news and new research.


What Caused These Skin Changes?
Xeroderma pigmentosum: Defective DNA repair causes skin cancer and neurodegeneration. Xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer. Specific UV-induced mutation spectrum in the p53 gene of skin tumors from DNA-repair-deficient xeroderma pigmentosum patients.


Using Biologic Agents Off-Label
These authors explore the myriad off-label uses for these versatile drugs.


Search Skin & Aging ArticlesAcne Article
Our extensive catalog of Skin & Aging journal articles is right at your fingertips!

Skin & Aging Supplements
Not Just Skin Deep: New Concepts & Approaches to Acne & "Actinic Keratosis"

This Supplement includes the proceedings from a Johns Hopkins CME Symposium

Dermatology SupplementsTHE MANY FACES OF ROSACEA
Topical Treatment of Rosacea: A Clinical Update

One out of every 22 people in the United States has rosacea, a chronic, progressive, inflammatory skin condition that causes a variety of facial cutaneous and ocular symptoms. Although rosacea predominantly affects adults between the ages of 30 and 50 years, 3 clinicians routinely treat patients with rosacea well into their 60s, 70s and even 80s.

Download PDF
Dermatology SupplementsCME Critical Reviews of Clinical Data:
Focus on Anti-TNF Agents for the Treatment of Psoriasis

Psoriasis is one of several systemic diseases presenting chiefly with cutaneous symptoms and with the potential to negatively impact the overall health and quality of life of patients.The immediate concern of most patients is likely to be prompt resolution of the skin involvement...

Download PDF and Take the Test Online
Dermatology SupplementsFall Clinical Dermatology 2007

An Update On Advance In Acne And Excerpts From What's New In The Medicine Cabinet

Download PDF
Dermatology SupplementsAcne Case Reports

Articles in this supplement are based on the proceedings from the 13th annual Acne Case Reports Roundtable Meeting.

Download PDF
Dermatology Supplements2007 ADVANCES IN COSMETIC & MEDICAL DERMATOLOGY “MAUI DERM” CONFERENCE

ARTICLES IN THIS SUPPLEMENT ARE BASED ON SELECTED PRESENTATIONS FROM THE ADVANCES IN COSMETIC & MEDICAL DERMATOLOGY “MAUI DERM” 2007 CONFERENCE HELD JANUARY 17-22, 2007, IN MAUI, HAWAII.

Download PDF
Dermatology Supplements July 2007 CME Supplement

Nonmelanoma skin cancer (NMSC) is the most common malignancy, affecting more than 1 million people in the United States alone.

Download PDF
Dermatology Supplements2007 Winter Dermatology Conference Hawaii®

Based on selected presentations from the Winter Dermatology Conference® held in Kohala Coast, Hawaii, January 13-17, 2007.

Download PDF
Dermatology Supplements2006 4th Annual Fall Conference Supplemental Proceedings

Articles in this supplement are based on selected presentations from the SDPA 4th Annual Fall CME Conference held November 8-11, 2006, in San Diego, CA.

Download PDF

About HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC, which also owns the North American Center for Continuing Medical Education (NACCME). NACCME provides a wide array of accredited CME offerings with industry thought leaders participating in roundtable meetings, webcasts, symposia, conferences, seminars, podcasts and satellite programs. Discover more about HMP’s products and services at www.hmpcommunications.com. ©2008 HMP Communications


© 2008 HMP Communications | Contact Us
83 General Warren Blvd, Suite 100 | Malvern, PA 19355